Thereby, with T2DM and with an increase in the duration of LH/hCG-R-agonists treatment, the StAR expression was decreased, and there were also multidirectional changes in the expression of steroidogenic enzymes that can compensate for dysfunctions of testicular steroidogenesis. This evidence concerns the gene PLOD1 and type 2 diabetes mellitus.